Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|November 29, 2011
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysisClaire L Vale, Jayne F Tierney, David Fisher, et al.
Trials|July 31, 2016
Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studiesAnnabelle South, Bec Hanley, Mitzy Gafos, et al.
Plos Medicine|May 6, 2021
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trialsJayne F Tierney, David J Fisher, Claire L Vale, et al.
BMJ Open|April 22, 2025
Treatment options for women with heavy menstrual bleeding: a protocol for comprehensive systematic review, network meta-analyses and health economic assessmentBassel H Al Wattar, Ewelina Rogozińska, Lily Nicholson, et al.
Plos One|July 8, 2022
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysisPeter J Godolphin, David J Fisher, Lindsay R Berry, et al.
The Lancet. Oncology|January 1, 2016
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate dataClaire L Vale, Sarah Burdett, Larysa H M Rydzewska, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisLarysa H M Rydzewska, Sarah Burdett, Claire L Vale, et al.
Lancet (London, England)|October 1, 2020
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataClaire L Vale, David Fisher, Andrew Kneebone, et al.
European Urology|March 4, 2019
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysisSarah Burdett, Liselotte M Boevé, Fiona C Ingleby, et al.
The Lancet. Oncology|July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trialsClaire L Vale, David J Fisher, Peter J Godolphin, et al.
Pageof 4